Juneteenth 2025 Meets Big Pharma: Are Black Americans Being ‘Monetized’ for Profit in New Health Campaigns?
The very first line of this year’s Juneteenth marketing blitz from major pharmaceutical companies isn’t about celebration—it’s about a new wave of “equity-driven” clinical trials targeting Black Americans for experimental drugs. With federal grants tied directly to Diversity, Equity, and Inclusion metrics, skeptics are asking: Who benefits when a historically painful anniversary is turned into a corporate recruitment tool? While the White House praises the “awareness,” leaked internal memos suggest these campaigns are designed to lower FDA approval costs, not to fix historical medical distrust. Is this a long-overdue correction or the biggest cash grab on racial trauma yet?